Pfizer may soon seek U.S. Food and Drug Administration emergency authorization of its COVID-19 booster shot for anyone aged 18 and older. Officials familiar with the situation told the Washington Post that the request could be filed as soon as this week and is likely to be supported by the FDA, according to the three […]